Navigation Links
Testosterone Lawsuit News: Bernstein Liebhard LLP Notes Recent Study Finding Dramatic Rise in Canadian Men Taking Hormone Therapy Treatments
Date:7/18/2014

New York, NY (PRWEB) July 18, 2014

Concerns surrounding certain testosterone treatments (http://www.injurybeacon.com/testosterone-androgel/) continued to reach new heights this month with a new study that found a significant increase in the number of Canadian men taking the medications over 15 years, Bernstein Liebhard LLP reports.

The study was published July 16th in an online version of the journal PLOS ONE, and revealed a 310 percent increase in Ontario men using testosterone-raising treatments between 1997 and 2012. According to a Huffington Post report that relayed its results, 28,477 men aged 66 and older were included in the research, which also found that only 6 percent of individuals taking the drugs were diagnosed with hypogonadism, a condition associated with abnormally-low levels of the hormone.*A number of testosterone lawsuits filed in the U.S. allege strokes, heart attacks, blood clots and other cardiovascular problems caused by hormone-raising treatments, court documents indicate.

“As our Firm continues to hear from men who allegedly sustained heart attacks, strokes deep vein thrombosis and other serious heart problems after taking AndroGel, Testim and several other medications, we find the results of this study deeply troubling,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential testosterone lawsuit evaluations to men who were allegedly harmed as a result of these hormone-raising therapies.

Testosterone Lawsuits
According to court documents updated on July 15th, a least 156 testosterone lawsuits are now pending in a multidistrict litigation (MDL) currently underway in the U.S. District Court, Northern District of Illinois. Cases filed in this proceeding allege that the makers of AndroGel and other medications failed to adequately warn men and about cardiovascular side effects that may stem from use of their products.

The litigation surrounding low testosterone therapies has continued to grow since January, when the U.S. Food and Drug Administration (FDA) issued a public health alert that vowed to investigate the safety of “Low T” testosterone medications. The warning was issued on January 31, 2014, after two studies revealed an increased risk for heart attacks, strokes and death in younger men with pre-existing heart disease and all older men.

Men who may have been harmed due to their use of drugs like Androgel may be entitled to file their own testosterone treatment lawsuit. To learn more, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*huffingtonpost.ca/2014/07/16/number-of-men-on-replacem_n_5592433.html,
Huffington Post, July 17, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.injurybeacon.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/testosterone-lawsuit/androgel-lawsuit/prweb12029668.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Number of Testosterone Therapy Lawsuits More than Doubles in Two-Week Period, Baron and Budd Reports
2. FDA Requires Testosterone Medication Manufacturers to Add Expanded Blood Clot Risk to Warning Labels, Baron and Budd Reports
3. Testosterone Treatment Lawsuit: Bernstein Liebhard LLP Notes Health Canada Alert on Possible Association Between Low Testosterone Therapy, Cardiovascular Problems
4. How much testosterone is too much for women after menopause?
5. No credible evidence to support cardiac risk of testosterone therapy
6. Low testosterone levels may indicate worsening of disease for men with prostate cancer
7. The Lancet Diabetes & Endocrinology: Large clinical trials to evaluate risks of testosterone treatment urgently needed
8. Screening instrument to identify testosterone deficiency
9. Male health linked to testosterone exposure in womb, study finds
10. Endocrine Society calls for large-scale studies to evaluate testosterone therapy risks
11. Testosterone isnt the help some hoped for when women go through menopause early
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the World Horse Expo ... Tom Seay and his production crew. Tom Seay’s program “Best of America by ... Saddle Sidekicks will be featured on April 6, 2017. After the broadcast, the ...
(Date:2/22/2017)... ... February 22, 2017 , ... The first-ever ... as organizations, advocates, and individuals join together to increase recognition about the risks ... save lives. , “Today we mark a nationwide movement to raise awareness about ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, the leading ... Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” http://www.beckersspine.com/spine-leaders/item/35348- ... in Michigan performing minimally invasive back surgery that often results in less post-operative ...
(Date:2/22/2017)... NJ (PRWEB) , ... February 22, 2017 , ... ... healthcare communications company, launched a new media platform connecting healthcare technology professionals and ... will be followed by a quarterly publication starting on March 1, announced Michael ...
(Date:2/22/2017)... ... February 22, 2017 , ... Super-Sod will attend the Athens Home Show ... Georgia. , A shift from Super-Sod’s simple Athens Home Show booth of 2016, this ... grass seed plant manager Chris Roquemore constructed furniture from recycled pallet wood at the ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... Conn. , Feb. 22, 2017   Protein ... maker of Flublok® Influenza Vaccine , announced today ... Partnership for Influenza Vaccine Introduction (PIVI) and the Mongolian ... devastating impacts of the flu.  The doses of Flublok ... Mongolia for health care workers, ...
(Date:2/22/2017)... PUNE, India , February 22, 2017 ... Market Research, titled, "Radiology Information System Market by Type, Component, ... Forecast, 2014-2022," the radiology information system market was valued at ... million by 2022, growing at a CAGR of 5.9% from ... over three-fifths share of the total market in 2015. ...
(Date:2/22/2017)... 22, 2017  Based on its recent analysis ... Sullivan recognizes SnooZeal, Inc. with the 2017 European ... innovative product that intelligently addresses the root causes ... through the clinically proven continuous transmucosal electrical stimulation ... is one of the most accessible anti-snoring products ...
Breaking Medicine Technology: